Dr. Joon Lee, CEO at Emory Healthcare

Yasir Tarabichi, a leader in medical informatics and clinical research, shares his insights on the growing use of AI in healthcare. As the Chief Medical Informatics Officer & Interim Medical Director at Ovatient and Director of Clinical Research Informatics at The MetroHealth System, Yasir addresses concerns about biases and financial investments in AI testing. He also expresses enthusiasm for the potential opportunities AI can bring to healthcare processes and workflows, while questioning how the FDA will regulate these new technologies.

In this episode, Dr. Onyinyechi Daniel, Vice President of Data & Analytics Strategy at Highmark Health, explores the landscape of Medicare Advantage, discussing the wins and challenges faced in this sector. He delves into trends in growth and development, emphasizing the critical roles of innovation and adaptability as well as highlights the importance of community in driving successful healthcare outcomes.

Tune in to the latest episode of the Becker's Healthcare Podcast, recorded live at our 14th Annual Meeting, where we delve into insightful discussions with industry experts. Join Trevor Wright, Chief Executive Officer at Loma Linda University Health Hospitals, as they share invaluable insights on leadership, growth strategies, and navigating workforce challenges in healthcare. Gain actionable advice and best practices to elevate your organization's performance in today's dynamic landscape.

In this episode of the Becker's Healthcare Podcast, host Laura Dyrda interviews Angela Jenkins, Vice President of Accountable Communities and Community Health at Prisma Health. Angela discusses her work in expanding access to care, addressing social determinants of health, and partnering with local organizations to improve community health. Tune in for insights on creating sustainable improvements in community health.

This episode features Erik Johnson, Senior Vice President of Optum Advisory Services. Here, he discusses how the pandemic has fundamentally reshaped hospital strategies and the extreme efforts made to develop a value-based care approach in this episode of Becker’s Healthcare. He also explores improvements in preventive and population health programs, providing insights into the future direction of healthcare and the critical measures being implemented to enhance patient outcomes and system efficiency.

In this episode, Jaja Okigwe, President and CEO of First Choice Health, outlines the goals and objectives driving his organization. He shares insights into the current trends he is monitoring in the healthcare industry, particularly the financial pressures and challenges that are shaping the landscape. Jaja offers his perspective on how to navigate these issues while maintaining a focus on high-quality patient care.

In this episode, Sean Cavanaugh, Chief Policy Officer at Aledade, Inc., delves into the intricacies of Medicare Advantage. He discusses various programs that impact value-based care and shares insights on how these initiatives are shaping the future of healthcare delivery. Sean provides a comprehensive overview of the policies and strategies that are driving improvements in patient outcomes and system efficiency.

In this episode, Dr. Stefano Sinicropi, President & CEO of the Midwest Spine & Brain Institute, shares his background, what distinguishes his organization, and the cutting-edge technologies in ortho biologics that excite him, along with other insights.

Tune in to the latest episode of the Becker's Healthcare Podcast, recorded live at our 14th Annual Meeting, where we delve into insightful discussions with industry experts. Join Morgan Ratcliffe, Chief Communication Officer at Providence Health Plan, as they share invaluable insights on leadership, growth strategies, and navigating workforce challenges in healthcare. Gain actionable advice and best practices to elevate your organization's performance in today's dynamic landscape.

This episode features Paige Twenter, Assistant Editor at Becker's Healthcare. Here, she discusses recent developments in the healthcare sector. Twenter highlights new research on the safety and risks associated with GLP-1 drugs, particularly Ozempic, and its potential benefits for chronic kidney disease. She also examines legislative changes affecting the 340B drug pricing program and their implications for hospitals and drug manufacturers, emphasizing the growing tension between these stakeholders.